Implementing the Medicare $2 drug list model would have reduced out-of-pocket spending by 63% for Part D beneficiaries in 2021. The model caps cost-sharing at $2 for a 30-day supply of 101 generic ...

One in six Medicare beneficiaries had a telehealth visit from 2021 to 2023, according to a study published in Annals of Internal Medicine. “Telehealth has become much more common post-[COVID-19] ...

Nation-wide rapid declines in prescription opioid dispensing gave rise to concerns regarding restricted access to effective pain management for patients with cancer-related pain. One important ...